Natalia Balko

QuintilesIMS

 Bio: Natalia Balko, Head of the Analytics Center of Excellence within R&D Solutions for QuintilesIMS, is responsible for the development, innovation, and delivery of global analytic solutions that underpin the Next Generation of Clinical Development Solutions following the QuintilesIMS merger.

Previously, Natalia was a Principal in Real World Insights, leading Corporate Strategy and Corporate Development initiatives, including the Quintiles and IMS Alliance that preceded the merger. Natalia has also held roles in Corporate Strategy at Onyx Pharmaceuticals prior to its acquisition by Amgen, and as a consultant within the IMS Consulting Group.

Natalia holds an undergraduate degree in Molecular Biology and Neuroscience from Princeton University, and an MBA from the Stanford Graduate School of Business.

Thursday April 27th , 2017
6:00 pm-
9:00 pm
Digital, Data and Technology: Disrupting Clinical Trials Only 1 in 5,000 medicines in development make it to market, with a drug typically taking 12 years to develop from initial discovery to market. Estimates vary but the Association of the British Pharmaceutical Industry puts drug development at £1.15bn per drug. If…